Dr. Alanna A. Morris’s research interests including studying the importance of non-modifiable risk factors such as race and gender, as well as social determinants of health that may contribute to excess disease in high risk populations. Her research examines the influence of these risk factors along the spectrum of heart failure, including clinical outcomes after heart transplantation and LVAD implantation. Currently, Dr. Morris is conducting a TCC Pilot Project entitled “Investigating the Impact of Georgia Medicaid Policy on Access, Resource Utilization, and Health Outcomes for Patients with Stage D Heart Failure”. Dr. Morris is also interested in the role of biomarkers of oxidative stress and endothelial dysfunction in patients with heart failure. She is currently the Principal Investigator of a research study examining the role of Metabolomics, Oxidative Stress, and Vascular Function in Heart Failure funded by NIH/NHLBI K23 (HL124287) and the Harold Amos Medical Faculty Development Program Scholar.
Dr. Morris joined the Emory Clinical Cardiovascular Research Institute faculty in 2013. Dr. Morris received her undergraduate degree in Biology from Xavier University of Louisiana, and her medical degree from the Harvard Medical School. She completed her residency at Brigham and Women’s Hospital in Boston, Massachusetts. Subsequently, she came to Emory University to complete fellowships in general cardiology, and advanced heart failure and transplant. After completion of her fellowship training, she was appointed Assistant Professor of Medicine in the Division of Cardiology at Emory University School of Medicine. She also holds a MSc degree from the Laney Graduate School of Emory University.